These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18344550)

  • 41. Quantitation of HIV-1 RNA in dried blood spots by the real-time NucliSENS EasyQ HIV-1 assay in Senegal.
    Kane CT; Ndiaye HD; Diallo S; Ndiaye I; Wade AS; Diaw PA; Gaye-Diallo A; Mboup S
    J Virol Methods; 2008 Mar; 148(1-2):291-5. PubMed ID: 18242718
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Single genome amplification of proviral HIV-1 DNA from dried blood spot specimens collected during early infant screening programs in Lusaka, Zambia.
    Seu L; Mwape I; Guffey MB
    J Virol Methods; 2014 Jul; 203():97-101. PubMed ID: 24667303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping.
    Chen JH; Wong KH; Chan K; Lam HY; Lee SS; Li P; Lee MP; Tsang DN; Zheng BJ; Yuen KY; Yam WC
    J Clin Virol; 2007 Jun; 39(2):125-31. PubMed ID: 17449318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disparate detection outcomes for anti-HCV IgG and HCV RNA in dried blood spots.
    Tejada-Strop A; Drobeniuc J; Mixson-Hayden T; Forbi JC; Le NT; Li L; Mei J; Terrault N; Kamili S
    J Virol Methods; 2015 Feb; 212():66-70. PubMed ID: 25445800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of in-house genotyping assay performance using dried blood spot specimens in the Global World Health Organization laboratory network.
    Parkin N; de Mendoza C; Schuurman R; Jennings C; Bremer J; Jordan MR; Bertagnolio S;
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S273-9. PubMed ID: 22544187
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of dried blood spots collected on filter papers from three manufacturers stored at ambient temperature for application in HIV-1 drug resistance monitoring.
    Rottinghaus EK; Beard RS; Bile E; Modukanele M; Maruping M; Mine M; Nkengasong J; Yang C
    PLoS One; 2014; 9(10):e109060. PubMed ID: 25303690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania.
    Johannessen A; Garrido C; Zahonero N; Sandvik L; Naman E; Kivuyo SL; Kasubi MJ; Gundersen SG; Bruun JN; de Mendoza C
    Clin Infect Dis; 2009 Sep; 49(6):976-81. PubMed ID: 19663598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of an in-house HIV-1 drug resistance genotypic testing for using dried blood spot specimens in China.
    Zhao H; Liao L; Xing H; Wang Z; Su B; Liu J; Wu J; Feng Y; He C; Ruan Y; Shao Y
    Curr HIV Res; 2015; 13(2):109-16. PubMed ID: 25495996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of a manual DNA extraction protocol and an isothermal amplification assay for detecting HIV-1 DNA from dried blood spots for use in resource-limited settings.
    Jordan JA; Ibe CO; Moore MS; Host C; Simon GL
    J Clin Virol; 2012 May; 54(1):11-4. PubMed ID: 22293626
    [TBL] [Abstract][Full Text] [Related]  

  • 50. No evidence for cross-contamination of dried blood spots excised using an office hole-punch for HIV-1 drug resistance genotyping.
    Buckton AJ; Prabhu DP; Cane PA; Pillay D
    J Antimicrob Chemother; 2009 Mar; 63(3):615-6. PubMed ID: 19158111
    [No Abstract]   [Full Text] [Related]  

  • 51. Evaluation of a dried blood and plasma collection device, SampleTanker(®), for HIV type 1 drug resistance genotyping in patients receiving antiretroviral therapy.
    Diallo K; Lehotzky E; Zhang J; Zhou Z; de Rivera IL; Murillo WE; Nkengasong J; Sabatier J; Zhang G; Yang C
    AIDS Res Hum Retroviruses; 2014 Jan; 30(1):67-73. PubMed ID: 23944768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of a dried blood spot HIV-1 RNA program for early infant diagnosis and viral load monitoring at rural and remote healthcare facilities.
    Lofgren SM; Morrissey AB; Chevallier CC; Malabeja AI; Edmonds S; Amos B; Sifuna DJ; von Seidlein L; Schimana W; Stevens WS; Bartlett JA; Crump JA
    AIDS; 2009 Nov; 23(18):2459-66. PubMed ID: 19741481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HemaSpot, a Novel Blood Storage Device for HIV-1 Drug Resistance Testing.
    Brooks K; DeLong A; Balamane M; Schreier L; Orido M; Chepkenja M; Kemboi E; D'Antuono M; Chan PA; Emonyi W; Diero L; Coetzer M; Kantor R
    J Clin Microbiol; 2016 Jan; 54(1):223-5. PubMed ID: 26560534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of HIV-1 detection in plasma specimens and dried blood spots using the Roche COBAS Ampliscreen HIV-1 test in Kisumu, Kenya.
    Okonji JA; Basavaraju SV; Mwangi J; Shiraishi RW; Odera M; Ouma K; Pitman JP; Marum LH; Ou CY; Zeh C
    J Virol Methods; 2012 Jan; 179(1):21-5. PubMed ID: 21777620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypes.
    Aitken SC; Kliphuis A; Wallis CL; Chu ML; Fillekes Q; Barth R; Stevens W; Rinke de Wit TF; Schuurman R
    J Clin Virol; 2012 May; 54(1):21-5. PubMed ID: 22306272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq 2.0 and an in-house method.
    Saravanan S; Vidya M; Balakrishnan P; Kumarasamy N; Solomon SS; Solomon S; Kantor R; Katzenstein D; Ramratnam B; Mayer KH
    J Virol Methods; 2009 Aug; 159(2):211-6. PubMed ID: 19490976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dried blood spots for HIV-1 drug resistance and viral load testing: A review of current knowledge and WHO efforts for global HIV drug resistance surveillance.
    Bertagnolio S; Parkin NT; Jordan M; Brooks J; García-Lerma JG
    AIDS Rev; 2010; 12(4):195-208. PubMed ID: 21179184
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.
    Dudley DM; Bailey AL; Mehta SH; Hughes AL; Kirk GD; Westergaard RP; O'Connor DH
    Retrovirology; 2014 Dec; 11():122. PubMed ID: 25533166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Feasibility of using dried blood spots to detect HIV drug resistance genotyping].
    Ma PF; Xing H; Liao LJ; Chen B; Zhao QB; Quan Y; Sun F; Yang SM; Su B; Chen X; Shao YM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Nov; 44(11):993-8. PubMed ID: 21215126
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV-1 and HCV detection in dried blood spots by SYBR Green multiplex real-time RT-PCR.
    De Crignis E; Re MC; Cimatti L; Zecchi L; Gibellini D
    J Virol Methods; 2010 Apr; 165(1):51-6. PubMed ID: 20045028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.